why choose us

First received: March 03, 2023

Clinical Trial: Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neovascular Age-related Macular Degeneration (nAMD)

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2 Two-Stage Dose Escalation and Randomized Parallel-Group Study to Evaluate the Safety, Preliminary Treatment Effects, and Durability of AR-14034 Sustained Release Implant Compared to I

Brief Summary: The primary purpose of this study is to evaluate the safety and durability of single- and repeat administration of AR-14034 Sustained Release (SR) in subjects with neovascular age-related macular degeneration (nAMD).

Read more